Kolaitis, N. A., Kingman, M., Wilson, M., Rendon, G. G., Lopez, D., Paoli, C. J., . . . Melendres‐Groves, L. (2025). Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i). Wiley. https://doi.org/10.1002/pul2.70113
Citazione stile Chigago Style (17a edizione)Kolaitis, Nicholas A., et al. Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i). Wiley, 2025. https://doi.org/10.1002/pul2.70113.
Citatione MLA (9a ed.)Kolaitis, Nicholas A., et al. Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i). Wiley, 2025. https://doi.org/10.1002/pul2.70113.